Skip to main content
Psychiatry
ALL Specialities
ALL Specialities
/
Psychiatry
COVID-19 Updates
News
From the Journals
FDA/CDC
Guidelines
Feature
Latest News
News by Conference
News from the FDA/CDC
Perspectives
Commentary
Curbside Consult
Families in Psychiatry
For Residents
From the Editor
Interview
Mental Health Consult
Shrink Rap News
Techiatry
Weighty Issues
Supplements
Reviews
Cases That Test Your Skills
Clinical Neuroscience
Evidence-Based Reviews
Med/Psych Update
Out of the Pipeline
Pearls
Savvy Psychopharmacology
CME
CME Supplements
Medical Education Library
Diseases and Conditions
Addiction Medicine
ADHD
Alzheimer's & Cognition
Anxiety Disorders
Bipolar Disorder
Depression
Eating Disorders
Movement Disorders
Personality Disorders
PTSD
Schizophrenia & Other Psychotic Disorders
Sleep Medicine
Somatic Disorders
Multimedia
Podcasts
Video
Resource Center
Lifestyle
News
EPO improves cognitive impairment in depression
Publish date:
September 20, 2016
AT THE ECNP CONGRESS
References
bjancin@frontlinemedcom.com
Pages
« first
1
2
Recommended Reading
The future of ketamine in psychiatry
MDedge Psychiatry
New guidelines to focus on mixed features in depression, bipolar
MDedge Psychiatry
SAGE-547 for depression: Cause for caution and optimism
MDedge Psychiatry
Major depressive disorder increases acute MI risk in HIV
MDedge Psychiatry
Type 2 diabetes peer-led intervention in primary care tied to improved depression symptoms
MDedge Psychiatry
VIDEO: When geriatric depression turns psychotic
MDedge Psychiatry
Low caregiver self-care linked with depression, anxiety
MDedge Psychiatry
It does get better ... with your help: Preventing suicide
MDedge Psychiatry
Cortical thinning may not be tied to executive dysfunction in late-life depression
MDedge Psychiatry
AUDIO: New NIMH director discusses future of depression therapy
MDedge Psychiatry
Depression
All Specialties
